Obstructive Laryngitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Obstructive Laryngitis Treatment Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc
Reckitt Benckiser Group PLC
Sun Pharmaceutical Industries Ltd.
Bayer AG
AstraZeneca
Novartis Pharmaceuticals Corporation
Walgreen Co.
Prestige Consumer Healthcare Inc.
Perrigo Company plc

Browse Key Market Insights with Data Illustration:

Obstructive Laryngitis Treatment Market Size & Share | Forecast Report 2036

In the News

October, 2022-Biohaven Pharmaceutical Holding Company Ltd., the manufacturer of NURTEC® ODT (rimegepant), an inventive migraine treatment authorized for the acute treatment as well as the prevention of episodic migraine in adults, was acquired by Pfizer Inc., it was reported.
July 2020 - The FDA in the United States has authorized AstraZeneca's Breztri Aerosphere as a maintenance medication for patients with chronic obstructive pulmonary disease (COPD).
Breztri Aerosphere, formerly known as PT010, is an inhalation medication that contains three active ingredients: the corticosteroid budesonide, the long-acting beta-2 agonist formoterol fumarate, and the long-acting muscarinic antagonist glycopyrronium.

Frequently Asked Questions (FAQ)

Prevalence of laryngitis disorders, minimally invasive surgical techniques, patient-centric, and adoption of personalized medicine are some of the major growth drivers for the obstructive laryngitis treatment market.

The market size of obstructive laryngitis treatment is anticipated to attain a CAGR of 5 % over the forecast period, i.e., 2024-2036.

The major players in the market are GlaxoSmithKline plc, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Bayer AG, AstraZeneca, Novartis Pharmaceuticals Corporation, Walgreen Co., Prestige Consumer Healthcare Inc., Perrigo Company plc, TAIHO PHARMACEUTICAL CO., LTD. and others.

The glucocorticoid segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Obstructive Laryngitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Obstructive Laryngitis Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the obstructive laryngitis treatment market?

What would be the CAGR of the obstructive laryngitis treatment market over the forecast period?

Who are the major players dominating the obstructive laryngitis treatment market?

Which segment captures the largest market size in the Medication segment in the obstructive laryngitis treatment market?

Which region will provide more business opportunities for the growth of the obstructive laryngitis treatment market in the future?